CompoAtlas

R-alpha lipoate de sodium in food supplements

122 supplements declared in France contain R-alpha lipoate de sodium as a substance or active ingredient.

Other names in the Compl'Alim list: Na-RALA, Sodium R-lipoate.

Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

In plain words

À quoi il sert, selon les fabricants

Objectifs les plus souvent annoncés pour les compléments qui en contiennent (R-alpha lipoate de sodium) : antioxydant (22 produits), immunité (7 produits), détoxifiant / draineur (5 produits), digestion (3 produits), circulation sanguine et lymphatique (2 produits).

Ce sont les objectifs déclarés par les fabricants à l'administration, pas des effets démontrés. Sur l'emballage, seules les allégations de santé autorisées par l'Union peuvent être écrites.

What the registers say, country by country

Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.

Compl'Alim ingredient list (France): listed.

Compl'Alim, reference list of ingredients, retrieved 21 October 2026.

United States, supplement labels (DSLD; supplements need no prior approval): 24 products.

Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Official warnings (Health Canada)

DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID

Route of administration: Oral

Cautions and warnings

Condition of application: All products.

Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).

3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.

Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).

4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

Health Canada monograph dated 27 June 2025

Texts from the monograph of Health Canada, the Canadian authority, reproduced without modification. They do not replace medical advice.

Products

Enter to analyse, Shift+Enter for a new line